Targets of the cyclin-dependent kinase Cdk1

被引:0
|
作者
Jeffrey A. Ubersax
Erika L. Woodbury
Phuong N. Quang
Maria Paraz
Justin D. Blethrow
Kavita Shah
Kevan M. Shokat
David O. Morgan
机构
[1] University of California,Departments of Physiology and Biochemistry & Biophysics
[2] Biophysics,Department of Cellular and Molecular Pharmacology
[3] University of California,undefined
[4] University of California,undefined
[5] Genomics Institute of the Novartis Foundation,undefined
来源
Nature | 2003年 / 425卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The events of cell reproduction are governed by oscillations in the activities of cyclin-dependent kinases (Cdks)1. Cdks control the cell cycle by catalysing the transfer of phosphate from ATP to specific protein substrates. Despite their importance in cell-cycle control, few Cdk substrates have been identified2. Here, we screened a budding yeast proteomic library for proteins that are directly phosphorylated by Cdk1 in whole-cell extracts. We identified about 200 Cdk1 substrates, several of which are phosphorylated in vivo in a Cdk1-dependent manner. The identities of these substrates reveal that Cdk1 employs a global regulatory strategy involving phosphorylation of other regulatory molecules as well as phosphorylation of the molecular machines that drive cell-cycle events. Detailed analysis of these substrates is likely to yield important insights into cell-cycle regulation.
引用
收藏
页码:859 / 864
页数:5
相关论文
共 50 条
  • [31] Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells
    Kang, Jian
    Sergio, C. Marcelo
    Sutherland, Robert L.
    Musgrove, Elizabeth A.
    BMC CANCER, 2014, 14
  • [32] Pharmacodynamic assessment of the cyclin-dependent kinase inhibitor flavopiridol: Modulation of cdk targets in clinical samples
    Di Vizio, D
    O'Connell, FP
    Bhattacharya, N
    Shapiro, GI
    Loda, M
    MODERN PATHOLOGY, 2005, 18 : 297A - 297A
  • [33] Cyclin-dependent Kinase 1 (CDK1)-mediated Phosphorylation of Enhancer of Zeste 2 (Ezh2) Regulates Its Stability
    Wu, Susan C.
    Zhang, Yi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (32) : 28511 - 28519
  • [34] Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B
    Catania, MG
    Mischel, PS
    Vinters, HV
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (07): : 711 - 723
  • [35] Regulation of Cell Surface Expression of Nucleolin by Phosphorylation by Cyclin Dependent Kinase Cdk1
    Chen, Xuguang
    Davis, Pamela B.
    MOLECULAR THERAPY, 2009, 17 : S128 - S129
  • [36] Cyclin-dependent kinase 1 (CDK1) and CDK2 have opposing roles in regulating interactions of splicing factor 3B1 with chromatin
    Murthy, Tushar
    Bluemn, Theresa
    Gupta, Abhishek K.
    Reimer, Michael
    Rao, Sridhar
    Pillai, Manoj M.
    Minella, Alex C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (26) : 10220 - 10234
  • [37] Clinical progress of selective cyclin-dependent kinase (CDK) inhibitors
    Misra, RN
    DRUGS OF THE FUTURE, 2006, 31 (01) : 43 - 52
  • [38] Underexpression of cyclin-dependent kinase (CDK) inhibitors in cervical carcinoma
    Kim, YT
    Cho, NH
    Park, SW
    Kim, JW
    GYNECOLOGIC ONCOLOGY, 1998, 71 (01) : 38 - 45
  • [39] 3D-QSAR CoMFA study on oxindole derivatives as cyclin dependent kinase 1 (CDK1) and cyclin dependent kinase 2 (CDK2) inhibitors
    Singh, Sanjeev Kumar
    Dessalew, Nigus
    Bharatam, Prasad V.
    MEDICINAL CHEMISTRY, 2007, 3 (01) : 75 - 84
  • [40] Homology models for CDK1 and CDK1/cyclin B
    McGrath, CF
    Pattabiraman, N
    Gussio, R
    Zaharevitz, DW
    Sausville, EA
    CLINICAL CANCER RESEARCH, 1999, 5 : 3780S - 3781S